We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeking Info to Develop Guidances on Host Cell Protein Risk and Biosimilars
FDA Seeking Info to Develop Guidances on Host Cell Protein Risk and Biosimilars
In its efforts to develop new guidances, the FDA is seeking information and comments on evaluating and mitigating the immunogenicity risk of host cell proteins (HCP) and the best way to advance development of new biosimilar biological products.